Literature DB >> 23072371

Bendamustine can severely impair T-cell immunity against cytomegalovirus.

Toru Hosoda, Akihiro Yokoyama, Mie Yoneda, Ryusuke Yamamoto, Kota Ohashi, Toshiya Kagoo, Hironori Ueno, Saigen Boku, Takahiro Yano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23072371     DOI： 10.3109/10428194.2012.739285

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  12 in total

1.  Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine.

Authors:  Monica Fung; Eric Jacobsen; Arnold Freedman; Daniel Prestes; Dimitrios Farmakiotis; Xiangmei Gu; Paul L Nguyen; Sophia Koo
Journal:  Clin Infect Dis       Date:  2019-01-07       Impact factor: 9.079

Review 2.  Entering the era of targeted therapy for chronic lymphocytic leukemia: impact on the practicing clinician.

Authors:  John C Byrd; Jeffrey J Jones; Jennifer A Woyach; Amy J Johnson; Joseph M Flynn
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

Review 3.  Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy.

Authors:  Catherine G Chung; Brian Poligone
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

4.  Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.

Authors:  I F Khouri; D Sui; E J Jabbour; B I Samuels; F Turturro; G Alatrash; P Anderlini; S Ahmed; B Oran; S O Ciurea; D Marin; A Olson; K K Patel; U R Popat; C Ledesma; T M Kadia; A Ferrajoli; J A Burger; J L Jorgensen; L J Medeiros; R L Bassett; A M Gulbis
Journal:  Bone Marrow Transplant       Date:  2016-09-05       Impact factor: 5.483

5.  Resolution of diarrhea in an immunocompromised patient with chronic norovirus gastroenteritis correlates with constitution of specific antibody blockade titer.

Authors:  Bettina M Knoll; Lisa C Lindesmith; Boyd L Yount; Ralph S Baric; Francisco M Marty
Journal:  Infection       Date:  2016-01-29       Impact factor: 3.553

6.  A case of Pneumocystis jiroveci pneumonia after bendamustine-based chemotherapy for refractory diffuse large B-cell lymphoma.

Authors:  Jeonghoon Ha; Yunhwa Jung; Yunduk Jung; Sanbin Lee; Yoonseo Lee; Insook Woo
Journal:  Blood Res       Date:  2016-03-25

7.  Severe Cytomegalovirus Reactivation in Patient with Low-Grade Non-Hodgkin's Lymphoma after Standard Chemotherapy.

Authors:  Lena Modvig; Ciaran Boyle; Katie Randall; Anton Borg
Journal:  Case Rep Hematol       Date:  2017-10-22

8.  Herpetic esophagitis following bendamustine-containing regimen.

Authors:  Hiromichi Yamane; Yasumasa Monobe; Tomohiro Tanikawa; Nobuaki Ochi; Yoshihiro Honda; Hirofumi Kawamoto; Nagio Takigawa
Journal:  Ther Clin Risk Manag       Date:  2016-06-02       Impact factor: 2.423

9.  Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma.

Authors:  H Saito; D Maruyama; A M Maeshima; S Makita; H Kitahara; K Miyamoto; S Fukuhara; W Munakata; T Suzuki; Y Kobayashi; H Taniguchi; K Tobinai
Journal:  Blood Cancer J       Date:  2015-10-23       Impact factor: 11.037

10.  Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.

Authors:  Mikhaila L Rice; Jason N Barreto; Carrie A Thompson; Kristin C Mara; Pritish K Tosh; Andrew H Limper
Journal:  Cancer Med       Date:  2021-06-22       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.